News & Events

Amy C. Justice, MD, PhD, C.N.H. Long Professor of Medicine (General Medicine) at Yale School of Medicine, professor of public health (health policy) at the Yale School of Public Health, and staff physician at the West Haven VA Medical Center, received the 2025 John M. Eisenberg National Award for Career Achievement in Research from the Society of General Internal Medicine (SGIM).

Emma Biegacki, MPH, program manager in the Section of General Internal Medicine, and Denise Brennan, medical coordinator in Medical Education, were honored with the 2025 Department of Internal Medicine Service Excellence Award at the Internal Medicine Staff Town Hall on April 30, 2025.

Meet Basile Njei, MD, MPH, PhD, assistant professor of medicine (digestive diseases). Njei is combining genetics and artificial intelligence (AI) to improve clinical outcomes, detect liver disease, and identify genetic and clinical predictors of liver disease. Njei is currently the co-director of the International Medicine Program in the Section of Digestive Diseases, through which he collaborates with the U.S. embassy in Cameroon to improve medical education and integrate AI into health care in Africa.

Fentanyl drives overdose deaths despite harm reduction—expert debate broader implications.

Rather than failing, harm reduction strategies, as articulated by Fiellin and colleagues in the New England Journal of Medicine is generating real benefits to patients and society.

The Pain Management Collaboratory Coordinating Center, a Yale-based research center that supports 16 large-scale pragmatic clinical trials of non-drug approaches to managing pain, has been awarded a funding extension to continue its work for six years.

A nationwide survey of U.S. psychiatric hospitals shows that fewer than 50% offer buprenorphine, methadone, and/or naltrexone, lifesaving medications that can treat opioid use disorder.

Hepatocellular carcinoma, a type of liver cancer, is the sixth most common cancer worldwide and the third leading cause of cancer-related deaths. Screening efforts for this cancer focus on individuals diagnosed with viral hepatitis or those known to have irreversible liver scarring, or cirrhosis. Due in part to increasing rates of obesity, another major risk factor is emerging, metabolic dysfunction-associated steatotic liver disease (MASLD), but factors associated with MASLD are not included in current screening practices. In response, researchers at Yale have developed and validated a new risk score for hepatocellular carcinoma that considers these factors. Their work, “Risk Score for Hepatocellular Cancer in Adults Without Viral Hepatitis or Cirrhosis” was published on November 6, 2024, in JAMA Network Open.

A research team led by lead author Galina A. Portnoy, PhD, assistant professor of psychiatry, found that bidirectional intimate partner violence was the most common relationship violence pattern, with no differences in gender between who experienced and used violence in the relationship.